Strategy update: protease-sparing regimens.

  • Published 1998 in Project Inform perspective


Protease-sparing regimens are sometimes considered the best initial therapy because they can effectively reduce viral load, while allowing the individual to reserve potent protease inhibitor therapy for later treatment. Others contend that the more potent therapy should be used first, to give a patient the best shot at long-term viral suppression. The… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.